hkex

The international arm of the Chinese mining giant has raised HK$25bn, the second biggest listing of the year.

The September 25 listing of the Chinese car giant is the largest IPO globally in the automobile sector in 2025.

Hong Kong-listed biotech firms are outperforming as Trump’s policies cause firms to change course from their traditional US destination, with more HKEX listings expected in the second half of 2025; experts shared their views at BIOHK.

The Chinese property giant had been placed into liquidation by Hong Kong's High Court in January 2024.

The Hong Kong Stock Exchange has eased IPO public float requirements and has made reforms in the IPO price discovery process; it is also carrying out a further consultation; meanwhile, listings continue apace.

The ETF, launched with BOCHK Asset Management, will track the iBoxx Tadawul Government & Agencies Sukuk Index; global sukuk issuance neared $200bn in 2024.

A core product for Type 2 diabetes is expected to commercially launch in mainland China by the end of this year, subject to regulatory approval; CICC led the transaction.

The rapid pandemic detection system BioRadar is developed by Hai Kang Life, which FA understands is in discussions with a number of countries and investors.

The dual listing will help keep momentum in Hong Kong's equity markets, with the majority of the $4.5bn proceeds raised by the Shenzhen based global EV player set to help build a factory in Hungary; a greenshoe option takes the raising to $5.2bn.